Primer akciğer kanserini taklit eden hepatoselüler karsinoma metastazı: Olgu sunumu

Hepatoselüler karsinoma (HCC) etyolojisinin temelinde hepatit B ve C virüslerinin (HBV, HCV) neden olduğu sirotik proçes yatmaktadır. Karaciğer transplantasyonu, seçilmiş olgularda sirozun ya da tümör ve altta yatan sirozun eş zamanlı tedavisinde seçenektir. Transplantasyon sonrası en sık rölaps izlenen sahalar akciğerler ve karaciğer allogreftidir. Soliter pulmoner rezektabl metastazlarda komplet rezeksiyonla sağkalım arttırılabilir. Bu makalede; HCV sirozu ön tanısıyla karaciğer transplantasyonu uygulanan ve 32 ay sonrasında primer akciğer kanseri ön tanısıyla sağ torakotomi ve alt lobektomi gerçekleştirilen 59 yaşındaki kadın hasta sunulmaktadır.

Hepatocellular carcioma metastasis mimicking primary lung cancer: Case report

Hepatitis B and C related cirrhosis process underlies on the basis of etiology of hepatocellular carcinoma (HCC). Liver transplantation is a choice of management in the treatment of cirrhosis or combined tumor and underlying cirrhosis, in selected patients. The most frequent relapsing sites after transplantation are lungs and liver allografts. Survival can be increased by complete resection in solitary pulmonary resectable metastasis. In this literature; 59 year old female patient, whom liver transplantation because of HCV cirrhosis prior diagnosis first and then right thoracotomy and lower lobectomy performed with prior diagnosis of primary lung cancer 32 months later, is presented.

PDF

___

1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.
3. Regalia E, Sansalone V, Reggiani GF, et al. Pattern of recurrence of hepatocellular carcinoma after liver transplantation: Milan multicenter experience. Transplant Proc 1994; 26: 3579-80.
4. Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17: 324.
5. Ferris JV, Baron RL, Marsh JW Jr, et al. Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 1996; 198: 233-8.
6. Freise CE, Ferrell L, Liu T, et al. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation 1999; 67: 510-3.
7. Viola C, Asselah T, Samuel D, et al. Solitary pulmonary metastasis arising thirteen years after liver transplantation for HBV-related hepatocellular carcinoma. World J Gastroenterol 2006; 12(30): 4911-3.
8. Kim KK, Kim JK, Kim DY, et al. Clinical outcome of pulmonary resections in patients with pulmonary metastasis of hepatocellular carcinoma. Korean J Hepatol. 2005; 11(4): 350-8.
9. Lam CM, Lo CM, Yuen WK, et al. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-200.
10. Yokoyama I, Carr B, Saitsu H, et al. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991; 68: 2095-100.
11. Marcellin P, Samuel D, Areias J, et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology 1994; 19: 6-12.